Close

ZIOP Financial Facts

Research contract revenue: 1.6M
Total operating expenses: 12.51M
See Full Income Statement

Prepaid expenses and other current assets: 20.97M
Additional paid-in capital - common stock: 582.23M
See Full Balance Sheet

ZIOPHARM (ZIOP) Earnings

  |   Expand Research on ZIOP
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -5.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/12 Q312 -$0.28-$0.29 +$0.01$200K$150K N/A Details
3/18/13 Q412 -$0.24-$0.29 +$0.05$200K$170K N/A Details
8/2/12 Q212 -$0.29-$0.26 -$0.03$200K$150K N/A Details
3/1/11 Q410 -$0.25-$0.24 -$0.01N/AN/A N/A Details
8/8/13 Q213 -$0.22-$0.24 +$0.02$200K$200K N/A Details
11/3/11 Q311 -$0.01-$0.24 +$0.23$200K$120K N/A Details
5/3/12 Q112 -$0.32-$0.23 -$0.09$200K$80K N/A Details
5/7/13 Q113 -$0.15-$0.23 +$0.08$200K$160K N/A Details